1. Howlander, N. et al. SEER Cancer Statistics Review, 1975–2012 (National Cancer Institute, 2015) Available at
http://seer.cancer.gov/csr/1975_2012/
(2015).
2. Hallek, M. et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111, 5446–5456 (2008).
3. Siddiqi, T. & Rosen, S. T. Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulation. Oncology (Williston Park) 29, 299–308 (2015).
4. Siddiqi, T. & Rosen, S. T. Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 1. Oncology (Williston Park) 29, 198–203 (2015).
5. Goldin, L. R. & Slager, S. L. Familial CLL: genes and environment. Hematology. Am. Soc. Hematol. Educ. Program 1, 339–345 (2007).